Atia Samim

Atia Samim

Auto-generated profile, based on publicly available information

Atia Samim

Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2017 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
ASAtia Samim
Atia Samim
ALAnnemieke S. Littooij
Annemieke S. Littooij
MHMarry M. van Den Heuvel-Eibrink
Marry M. van Den Heuvel-Eibrink
FWFrank J. Wessels
Frank J. Wessels
RNRutger A. J. Nievelstein
Rutger A. J. Nievelstein
PJPim A. de Jong
Pim A. de Jong
Background Normative data on pulmonary nodules in children without malignancy are limited. Knowledge of the frequency and characteristics of pulmonary nodules in healthy children can influence care decisions in children with malignant disease. Objective To provide normative data concerning the frequency and characteristics of pulmonary nodules on computed tomography (CT) in young children. Materials and methods All children ages 1 year–12 years who underwent chest CT after high-energy trauma were retrospectively investigated. Exclusion criteria were a history of malignancy, thick image slices, motion artefacts and extensive post-traumatic pulmonary changes. Two radiologists were asked to independently identify all nodules and to characterize each nodule with respect to location, size, perifissural location and calcification. Discrepancies were adjudicated by a third reader, who set the reference standard in this study. Interobserver agreement in detection and characterization was assessed using the kappa coefficient (κ). Results Identified were 120 patients, of whom 72 (75% male; median age: 8.0 years [interquartile range: 4–11]) were included. A total of 59 pulmonary nodules were present in 27 patients (38%; 95% confidence interval: 26–49%; range: 1–5 nodules per patient, with a mean diameter of 3.2 mm [standard deviation: 0.9 mm]). For nodule detection, the per-patient interobserver agreement was substantial (κ=0.78) and per-lobe agreement was moderate (κ=0.40). For characterization, there was fair to substantial agreement (κ=0.36–0.74). Conclusion Small pulmonary nodules on chest CT are a common finding in otherwise healthy children, but detection and characterization have only moderate interobserver agreement.

16 March 2024 in EJC Paediatric Oncology
Verified
Journal Article
Open access
ASAtia Samim
Atia Samim
GBGitta Bleeker
Gitta Bleeker
KKKathelijne C.J.M. Kraal
Kathelijne C.J.M. Kraal
MNMax M. van Noesel
Max M. van Noesel
BKBart De Keizer
Bart De Keizer
GTGodelieve A.M. Tytgat
Godelieve A.M. Tytgat

2 April 2025 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
ASAtia Samim
Atia Samim
DSDiederik P. D. Suurd
Diederik P. D. Suurd
RRRob van Rooij
Rob van Rooij
MNMax M. Van Noesel
Max M. Van Noesel
MLMarnix G.E.H. Lam Lam
Marnix G.E.H. Lam Lam
BKBart De Keizer
Bart De Keizer
Purpose: Meta-[1⁸F]fluorobenzylguanidine ([1⁸F]mFBG) PET-CT is a novel imaging modality for norepinephrine transporter-expressing tumours, such as neuroblastoma and phaeochromocytoma, enabling quantitative assessment and improved diagnostic accuracy compared to meta-[123I]iodobenzylguanidine ([123I]mIBG) scintigraphy. This study aims to: 1) Identify the optimal standardised uptake value (SUV) normalisation method: body weight (BW) or lean body mass (LBM); 2) Determine the most stable reference tissue with SUV uptake below pathological levels. Methods: We analysed 63 [1⁸F]mFBG PET-CTs from 35 patients (20 paediatric neuroblastoma, 15 adult phaeochromocytoma). SUVmean was measured in the liver, blood pool, bone marrow, and muscle, normalised using BW (SUVBW), LBM via James (SUVLBMJames), and LBM via Janmahasatian (SUVLBMJanma). Variability of SUVs and their correlation with weight were assessed. Results: LBM-based normalisation reduced SUV variability compared to BW-based normalisation. Bone marrow demonstrated the lowest variability and least weight dependency (r2 0.45 for SUVBW versus 0.31 for SUVLBMJanma). The liver had the highest SUVs, increasing the risk of false negatives if used as reference tissue, while the blood pool had the lowest SUVs, raising the risk of false positives. Muscle showed relatively stable SUVs with increasing weight but higher variability than bone marrow. Conclusion: LBM-based SUV normalisation reduces weight dependency for [1⁸F]mFBG PET-CT. Bone marrow is the most reliable reference tissue due to its low variability and balanced SUVs, while muscle may serve as an alternative if diffuse bone marrow uptake is present. These findings support standardising LBM-adjusted SUV methods and using bone marrow as the primary reference tissue to enhance diagnostic accuracy. Clinical trial registration: EudraCT Number: 2019–003713-33; EU Clinical Trials Number: 2024–513622-35–00.

1 January 2025 in JCO Precision Oncology
Verified
Journal Article
Open access
YMYvette A.H. Matser
Yvette A.H. Matser
ASAtia Samim
Atia Samim
MFMarta Fiocco
Marta Fiocco
MMMarieke van de Mheen
Marieke van de Mheen
MHMaria van der Ham
Maria van der Ham
GTGodelieve A.M. Tytgat
Godelieve A.M. Tytgat
PURPOSE: Urinary catecholamine metabolites are well-known biomarkers for the diagnosis (Dx) of neuroblastoma, but their clinical significance in determining therapy response during treatment is not well established. Therefore, catecholamines are not included in criteria for assessing response and complete remission (CR). This study investigated the use of urinary catecholamines in response monitoring and predicting survival outcomes. METHODS: From 2005 to 2021, a panel of eight urinary catecholamines were measured in patients with high-risk neuroblastoma at Dx and at standard evaluation moments during treatment. At the same time points, response and CR were assessed according to the revised International Neuroblastoma Response Criteria. RESULTS: The total cohort consists of 153 high-risk patients, and at least one of the eight metabolites was elevated (ie, catecholamine status positive) in 141 of 146 (97%), 104 of 128 (81%), and 39 of 69 (57%) patients at Dx, postinduction, and at CR, respectively. Primary tumor resection significantly reduced catecholamine levels ( P < .01). A positive catecholamine status at Dx, during treatment, and at the end of treatment was not significantly associated with event-free survival (EFS) or overall survival (OS). However, in patients who achieved CR, those with a positive catecholamine status had poor EFS (38% v 80%, respectively; P < .01) and OS (52% v 86%, respectively; P = .01) compared with those with a negative catecholamine status. Notably, 3-methoxytyramine levels at CR seem to be a prognostic marker for poor OS (hazard ratio, 7.5 [95% CI, 2.0 to 28.6]). CONCLUSION: Catecholamine measurements contribute to the assessment of CR and identifies patients with high-risk neuroblastoma with an increased risk of relapse and death.

29 August 2023 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
ASAtia Samim
Atia Samim
SSSuzanne Spijkers
Suzanne Spijkers
PMPim Moeskops
Pim Moeskops
ALAnnemieke S. Littooij
Annemieke S. Littooij
PJPim A. de Jong
Pim A. de Jong
RNRutger A. J. Nievelstein
Rutger A. J. Nievelstein
Background: Body composition during childhood may predispose to negative health outcomes later in life. Automatic segmentation may assist in quantifying pediatric body composition in children. Objective: To evaluate automatic segmentation for body composition on pediatric computed tomography (CT) scans and to provide normative data on muscle and fat areas throughout childhood using automatic segmentation. Materials and methods: In this pilot study, 537 children (ages 1–17 years) who underwent abdominal CT after high-energy trauma at a Dutch tertiary center (2002–2019) were retrospectively identified. Of these, the CT images of 493 children (66% boys) were used to establish normative data. Muscle (psoas, paraspinal and abdominal wall) and fat (subcutaneous and visceral) areas were measured at the third lumbar vertebral (L3) level by automatic segmentation. A representative subset of 52 scans was also manually segmented to evaluate the performance of automatic segmentation. Results: For manually-segmented versus automatically-segmented areas (52 scans), mean Dice coefficients were high for muscle (0.87–0.90) and subcutaneous fat (0.88), but lower for visceral fat (0.60). In the control group, muscle area was comparable for both sexes until the age of 13 years, whereafter, boys developed relatively more muscle. From a young age, boys were more prone to visceral fat storage than girls. Overall, boys had significantly higher visceral-to-subcutaneous fat ratios (median 1.1 vs. 0.6, P<0.01) and girls higher fat-to-muscle ratios (median 1.0 vs. 0.7, P<0.01). Conclusion: Automatic segmentation of L3-level muscle and fat areas allows for accurate quantification of pediatric body composition. Using automatic segmentation, the development in muscle and fat distribution during childhood (in otherwise healthy) Dutch children was demonstrated.

1 March 2026 in JCO Precision Oncology
Verified
Journal Article
Open access
YMYvette A. H. Matser
Yvette A. H. Matser
AKAndré B. P. van Kuilenburg
André B. P. van Kuilenburg
ASAtia Samim
Atia Samim
LLLotte M. van Liempt
Lotte M. van Liempt
MGMartine van Grotel
Martine van Grotel
GTGodelieve A.M. Tytgat
Godelieve A.M. Tytgat
PURPOSE: MYCN amplification ( MYCN -A) is an important prognostic marker in neuroblastoma. However, the impact of MYCN -A in patients with metastasized high-risk neuroblastoma during the course of disease remains unclear. The aim of this study was to investigate response and relapse patterns of stage IV patients with and without amplification of MYCN . MATERIALS AND METHODS: Amplification of the MYCN oncogene was assessed by fluorescence in situ hybridization, whole exome sequencing, or single nucleotide polymorphism analysis. Complete remission (according to the revised International Neuroblastoma Response Criteria) and survival outcomes were estimated. RESULTS: Among the 164 patients older than 12 months with metastatic high-risk neuroblastoma, 50 (30%) had MYCN -A. MYCN -A was a significant prognostic marker for overall survival ( P = .04). Patients with MYCN -amplified tumors reached complete remission faster compared with those without MYCN amplification (HR, 1.8 [95% CI, 1.2 to 2.8]; P < .01). MYCN -A was associated with recurrence when evaluated from diagnosis and after induction treatment (HR, 1.6 [95% CI, 1.0 to 2.4]; and HR, 1.8 [95% CI, 1.1 to 2.8], respectively), as well as to the cumulative incidence of recurrence ( P = .04 and P = .03, respectively). SIOPEN scores detected on meta -[ 123 I]iodobenzylguanidine (MIBG) scintigraphy were significantly lower in patients with MYCN -amplified tumors than in patients with MYCN nonamplified tumors at diagnosis and after induction treatment ( P < .01 and P = .01, respectively). From end of induction, MYCN -A stratified by SIOPEN score was associated with the cumulative incidence of recurrence ( P < .01). CONCLUSION: Despite achieving complete remission faster, patients with MYCN -A have a higher probability of recurrence compared with those without MYCN -A.